Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» R&D
R&D
The 10 highest value R&D projects in biopharma
Fierce Biotech
Wed, 09/6/23 - 10:17 am
R&D
biotech
Merck
sotatercept
Daiichi Sankyo
AstraZeneca
Dato-DXd
Novo Nordisk
CagriSema
Eli Lilly
donanemab
Karuna Therapeutics
Zai Lab
KarXT
Moderna Therapeutics
mRNA-1647
Novartis
iptacopan
Madrigal Pharmaceuticals
resmetirom
Cytokinetics
aficamten
Roche
Chugai
tiragolumab
Sanofi appoints a venture investor to R&D head as executive team expands
BioPharma Dive
Thu, 08/31/23 - 06:05 pm
Sanofi
R&D
Houman Ashrafian
AI Is Game Changer For Toughest Areas Of Drug Discovery
Forbes
Thu, 08/31/23 - 11:45 am
artificial intelligence
drug discovery
R&D
J&J ends R&D at Janssen's infectious disease and vaccine unit
Fierce Biotech
Wed, 08/23/23 - 05:40 pm
JNJ
infectious disease
vaccines
R&D
Foundery, a new biotech venture firm, sets out to speed early immune drug research
BioPharma Dive
Tue, 08/22/23 - 09:42 am
Foundery
immunology
R&D
venture capital
funding
Astellas to Open New Life Sciences Facility in DivcoWest's Cambridge Crossing Neighborhood
PR Newswire
Wed, 08/9/23 - 10:36 pm
Astellas
Cambridge MA
R&D
IRA Creates Unintended Complications for Biologics
BioSpace
Wed, 08/9/23 - 10:11 am
legislation
Inflation Reduction Act
R&D
biologics
Daiichi Sankyo to close Japanese research and development subsidiary
Pharmaceutical Business Review
Tue, 08/8/23 - 10:17 am
Daiichi Sankyo
Japan
R&D
RD Novare
Aiming to be biggest biotech in Boston, Vertex plots 500-person cell, gene therapy R&D center
Fierce Biotech
Fri, 08/4/23 - 12:15 pm
Vertex Pharmaceuticals
cell therapy
gene therapy
R&D
Boston
Cholesterol-focused Esperion loses appetite for oral PCSK9 collab with Serometrix
Fierce Biotech
Tue, 08/1/23 - 11:57 am
Esperion Therapeutics
R&D
Serometrixjm
PCSK9 inhibitors
cholesterol
Pfizer shuffles R&D leadership to prepare for Seagen merger
Fierce Biotech
Thu, 07/27/23 - 11:44 am
Pfizer
R&D
M&A
Seagen
Biogen to eliminate 1,000 jobs in further cost cuts
BioPharma Dive
Tue, 07/25/23 - 11:58 am
Biogen
layoffs
R&D
Pfizer and Moderna’s parent are investing $100 million in a new partnership to find the next big drug
Yahoo/Fortune
Tue, 07/25/23 - 10:22 am
Pfizer
Flagship Pioneering
Moderna Therapeutics
R&D
drug development
A leading CRO’s chief exec on why a ‘brave new world’ of clinical research is here
Pharma Voice
Fri, 07/21/23 - 10:05 am
Worldwide Clinical Trials
CROs
R&D
clinical trials
Sanofi outlines five-pronged approach to reel in €10B in vaccine sales by 2030
Fierce Pharma
Thu, 06/29/23 - 11:09 pm
Sanofi
vaccines
R&D
Alphabet's quantum spinoff starts working with AstraZeneca, Sanofi to accelerate R&D
Fierce Biotech
Fri, 06/23/23 - 10:01 am
Alphabet
SandboxAQ
AstraZeneca
Sanofi
R&D
funding
molecular simulation
artificial intelligence
AstraZeneca returns to hypercholesterolemia via R&D pact with fresh-faced Chinese biotech
Fierce Biotech
Fri, 06/16/23 - 09:59 am
AstraZeneca
hypercholesterolemia
R&D
Cholesgen
Unpartnered assets: on the shelf or hidden treasure?
EP Vantage
Thu, 06/15/23 - 09:54 am
R&D
ALX Oncology
Argenx
Ascendis Pharma
Cytokinetics
Karuna Therapeutics
Madrigal Pharmaceuticals
Protagonist Therapeutics
Prothena
Ultragenyx Pharmaceutical
Unique Pharma
Ventyx Biosciences
Coya deems dementia drug R&D plan 'premature,' switches focus
Fierce Biotech
Mon, 06/12/23 - 10:00 am
Coya Therapeutics
R&D
frontotemporal dementia
dementia
tregs
Epistemic AI launches biomedical GPT at BIO
Pharmaphorum
Fri, 06/9/23 - 10:18 am
artificial intelligence
BIO 2023
R&D
Epistemic AI
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »